MODEL FOR PREDICTION AND PREVENTION OF ADVERSE PERINATAL OUTCOMES IN COVID-19 IN WOMEN
DOI:
https://doi.org/10.32782/2306-2436.15.2.2025.326Keywords:
COVID-19, pregnancy, perinatal care, prediction, prevention, modelAbstract
Relevance. The task of developing a model for predicting and preventing adverse perinatal outcomes in women with COVID-19 is relevant, which should provide an effective clinical solution taking into account individual and regional characteristics, which will contribute to reducing maternal and perinatal morbidity and mortality. Purpose. To create a tool for early identification of pregnant women with a high risk of complications in case of COVID-19 to reduce maternal and perinatal mortality, prevent adverse perinatal complications (using the example of Ivano-Frankivsk region).Materials and methods. The creation of a model for predicting and preventing adverse perinatal outcomes in case of COVID-19 in women is based on research using the bibliosemantic research method, the method of structural-logical analysis, analytical, statistical and conceptual methods, clinical, anamnestic and laboratory-instrumental methods, and questionnaires. Results. The medical and social justification, principles of formation and expected results of the implementation of the model of prediction and prevention of adverse perinatal consequences of COVID-19 in women are presented. The development and implementation of such a model can be carried out in 5 stages over 3 years: preparatory and analytical (1–2 quarters of the 1st year); creation and testing of a digital model (3–4 quarters of the 1st year); pilot implementation in the region (1–2 quarters of the 2nd year); scaling and integration (3–4 quarters of the 2nd year); effectiveness assessment and continuous improvement (3rd year and beyond). Model components: screening stage (at the primary level); prediction stage (secondary level); response stage (tertiary level); information support and monitoring. Conclusions. The practical implementation of the developed model allows improving the quality of medical care for pregnant women during the pandemic, optimizing the use of healthcare system resources, reducing the incidence of complications and improving perinatal outcomes even in conditions of limited resources.
References
1. Dashraath P., Wong JLJ, Lim MXK, Lim LM, Li S., Biswas A. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020 Jun; 222(6):521–531. DOI: 10.1016/j.ajog.2020.03.021
2. Chen L., Li Q., Zheng D., Jiang H., Wei Y., Zou L., et al. Clinical characteristics of pregnant women with COVID-19 in Wuhan, China. N Engl J Med. 2020 Jun 18;382(25):e100. DOI: 10.1056/NEJMc2009226
3. Allotey J., Stallings E., Bonet M., Yap M., Chatterjee S., Kew T., et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020 Sep;370:m3320. DOI: 10.1136/bmj.m3320
4. Villar J., Ariff S., Gunier RB. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021 Aug 1;175(8):817-826. DOI: 10.1001/jamapediatrics.2021.1050.
5. Wastnedge EAN, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, et al. Pregnancy and COVID-19. Physiol Rev. 2021 Jan;101(1):303–318. DOI: 10.1152/ physrev.00024.2020
6. Metz TD, Clifton RG, Hughes BL, Sandoval G, Grobman WA, Saade GR, et al. Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications. JAMA. 2022 Feb;327(8):748–759. DOI: 10.1001/jama.2022.1190
7. Chen R., Liang W., Jiang M., Guan W., Zhan C., Wang T. Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China. Chest. 2020 Jul;158(1):97–105. DOI: 10.1016/ j.chest.2020.04.010
8. World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020 [Internet]. Geneva: WHO; 2020 [cited 2025 Jun 27]. URL: https://apps.who.int/iris/ handle/10665/332196
9. Aabakke A. J. M., Petersen T. G., Wojdemann K. et al. Risk factors for and pregnancy outcomes after SARS-CoV-2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS-CoV-2 diagnosis. Acta Obstetricia et Gynecologica Scandinavica. 2023; 3 (102): 282–293. DOI: https://doi.org/10.1111/aogs.14512
10. FIGO Working Group on Good Clinical Practice in Maternal–Fetal Medicine. Management of pregnant women with COVID-19: a FIGO position paper. Int J Gynaecol Obstet. 2020 Dec;151(3):146–153.
11. Ministry of Health of Ukraine. Unified clinical protocol for primary, secondary (specialized) and tertiary (highly specialized) medical care "COVID-19". Order of the Ministry of Health of Ukraine No. 762 of 02.04.2020. [Internet]. [cited 2025 Jun 27]. DOI: https://moz.gov.ua/
12. Рябоконь О. В., Черкаський В. В., Рябоконь Ю. Ю. Коронавірусна хвороба у вагітних: сучасний стан питання . Інфекційні хвороби. 2021; 1 (103): 45–52. DOI: 10.11603/1681-2727.2021.1.11950
13. Малачинська М. Й. Управління перинатальною допомогою під час пандемії COVID-19 в Україні: організаційно-правовий механізм. Демократичне врядування. 2023;16(1): 185-197. DOI: https://doi.org/10.23939/dg2023.01.185.
14. Kaminskiy V. V., Zhdanovych O. I., Savchuk R. M., Kolomiichenko T.V. Assessment of the perinatal care effectiveness during the COVID-19 pandemic at the regional level. FAMILY MEDICINE. EUROPEAN PRACTICES. 2024; 2 (108): 13–20 DOI: https://doi.org/10.30841/2786-720X.2.2024.307506.
15. Kaminskiy V. V., Zhdanovych O. I., Savchuk R. M., Kolomiichenko T. V. Determinants of perinatal medical care at the ambulatory level in the conditions of the COVID-19 pandemic REPRODUCTIVE HEALTH OF WOMAN. 2024; 3(74):10–17. DOI: https://doi.org/10.30841/2708-8731.3.2024.306389
16. Zhdanovych O. I., Savchuk R. M. ASSESSMENT OF THE VOLUME OF PERINATAL CARE DURING THE COVID- 19 PANDEMIC IN A SEPARATE REGION Scientific Digest of Association of Obstetricians and Gynaecologists of Ukraine. 2024. 2(54):22–28. DOI: https://doi.org/10.35278/2664-0767.2 (54).2024.321596
17. Камінський В., Жданович О., Савчук Р., Коломійченко Т., Семенченко О. Медико-соціальні фактори ризику розвитку перинатальних порушень у жінок при COVID-19. Сімейна Медицина. Європейські практики, 2025 (2): 33–38. DOI: https://doi.org/10.30841/2786-720X.2.2025.331922
